September 18, 2025 · Form 4 insider transaction
Gline Matthew bought 3,315 shares of Roivant Sciences Ltd. at $15.07 per share, a transaction worth $50.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range.